2016 American Transplant Congress » Joint Plenary Session II

Date: Monday, June 13, 2016

Time: 8:30am-9:30am

Location: Veterans Auditorium

Session Type: Plenary

Meeting: 2016 American Transplant Congress

8:30am-8:45am: Ledipasvir/Sofosbuvir (LDV/SOF) for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 HCV Infection.

S. Pol,¹ A. Aghemo,² L. Lin,³ R. Hyland,³ C. Yun,³ J. Spellman,³ M. Natha,³ D. Brainard,³ J. McHutchison,³ M. Bourlière,⁴ M. Peck-Radosavljevic,⁶ M. Michael,⁵ M. Colombo.²

8:45am-9:00am: Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.

M. Ezzelarab,¹ H. Zhang,¹ L. Lu,¹ H. Guo,¹ A. Zahorchak,¹ R. Wiseman,² M. Nalesnik,³ J. Bhama,¹ D. Cooper,¹ A. Thomson.^1,4

9:00am-9:15am: Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the SIMCER Study.

F. Saliba,¹ C. Duvoux,² S. Dharancy,³ J. Dumortier,⁴ Y. Calmus,⁵ F. Di Giambattista,⁶ F. Conti.⁵

9:15am-9:30am: Prevalence of Polyreactive Innate-Like B Cells Among Graft-Infiltrating B Cells in Human Cardiac Allograft Vasculopathy.

D. Chatterjee,¹ C. Moore,² B. Gao,³ K. Clerkin,¹ S. See,¹ D. Shaked,¹ K. Rogers,¹ S. Nunez,¹ Y. Veras,¹ L. Addonizio,¹ M. Givertz,⁴ Y. Naka,¹ D. Mancini,¹ R. Vasilescu,⁵ C. Marboe,⁵ S. Restaino,¹ J. Madsen,² E. Zorn.¹

« View all sessions from the 2016 American Transplant Congress